Introduction:
The Regulatory Affairs Certification Exam is designed to evaluate and strengthen the understanding of pharmaceutical regulatory systems and drug approval processes. Regulatory affairs professionals play a crucial role in ensuring that pharmaceutical products meet national regulatory requirements before they are marketed. This certification focuses on key regulatory principles, documentation procedures, and approval pathways governed by the Central Drugs Standard Control Organization (CDSCO). The exam helps learners develop knowledge about regulatory compliance, drug registration processes, and the regulatory framework that ensures the safety, quality, and efficacy of pharmaceutical products.

Scope:
The certification covers important aspects of pharmaceutical regulatory affairs, including CDSCO regulatory structure, drug approval pathways, clinical trial permissions, and regulatory documentation. It also includes regulatory submissions, dossier preparation, compliance with national drug regulations, labeling requirements, and post-marketing regulatory responsibilities. The program provides an overview of how regulatory authorities oversee pharmaceutical product development, approval, and lifecycle management.

Objectives:

• To assess knowledge of pharmaceutical regulatory affairs and drug regulatory frameworks.
• To provide understanding of CDSCO guidelines and drug approval processes in India.
• To evaluate familiarity with regulatory documentation and submission requirements.
• To strengthen awareness of compliance, labeling regulations, and post-marketing obligations.
• To prepare candidates for regulatory affairs roles within pharmaceutical organizations.

Who can enroll:

• B.Pharm, M.Pharm, and Pharm.D students and graduates.
• Pharmacy professionals working in regulatory affairs, quality assurance, or pharmaceutical compliance roles.
• Fresh graduates interested in pursuing careers in pharmaceutical regulatory affairs.
• Professionals seeking to enhance their understanding of CDSCO regulations and drug approval processes in the pharmaceutical industry.